青黴素每日序貫給藥與常規靜滴療法217例的成本－效果分析

Cost-effectiveness Analysis of Daily Sequential Administration and Routine Intravenous Drip Therapy with Penicillin in 217 Patients with Upper Respiratory Tract Infection

枉前(Qian Wang)；張恩娟(En-Juan Zhang)；盧來春(Lai-Chun Lu)；劉同華(Tong-Hua Liu)；樊莉(Li Fan)

青黴素 ； 合理用藥 ； 成本－效果分析 ； penicillin ； rational drug use ； cost-effectiveness analysis

藥學服務與研究

5卷2期（2005 / 06 / 01）

126 - 128

簡體中文

Objective: To compare the cost-effectiveness of daily sequential administration and routine intravenous drip therapy with penicillin in patients with upper respiratory tract infection, and provide a new method for rational use of penicillin. Methods: Patients with upper respiratory tract infection were divided into two groups: daily sequential administration group (penicillin, ivd. +po. , 112 patients) and routine intravenous drip therapy group (penicillin, ivd. , 105 patients). The results of different administration methods were analyzed using direct cost-effectiveness analysis method, including discussion of indirect cost and recessive cost. Results: Effective rates of two groups were 91.0% and 94.3%, respectively (P＞0.05). Cost-effectiveness ratio of daily sequential administration group (2.04) was lower than that of routine intravenous drip therapy group (3.11) (P＜0.05). Conclusion Daily sequential administration has lower cost effectiveness ratio in treatment of patients with upper respiratory tract infection. It may be a choice to use penicillin rationally and economically.

Objective: To compare the cost-effectiveness of daily sequential administration and routine intravenous drip therapy with penicillin in patients with upper respiratory tract infection, and provide a new method for rational use of penicillin. Methods: Patients with upper respiratory tract infection were divided into two groups: daily sequential administration group (penicillin, ivd. +po. , 112 patients) and routine intravenous drip therapy group (penicillin, ivd. , 105 patients). The results of different administration methods were analyzed using direct cost-effectiveness analysis method, including discussion of indirect cost and recessive cost. Results: Effective rates of two groups were 91.0% and 94.3%, respectively (P＞0.05). Cost-effectiveness ratio of daily sequential administration group (2.04) was lower than that of routine intravenous drip therapy group (3.11) (P＜0.05). Conclusion Daily sequential administration has lower cost effectiveness ratio in treatment of patients with upper respiratory tract infection. It may be a choice to use penicillin rationally and economically.